Page 735 - Clinical Small Animal Internal Medicine
P. 735

64  Canine Inflammatory Liver Disease  703

               affected dogs was 7.8 +/− 4.1 years, with a range of 2.4–  parenchyma was found to be normal in seven dogs,
  VetBooks.ir  14.5 years. No comprehensive study has been performed   irregular in 11, and to have increased echogenicity in
                                                                  three. Interestingly, three dogs with AH had evidence of
               to determine the breed predispositions to AH, although
               in this same study, Jack Russell terriers may have been at
                                                                   It is not possible to make a definitive diagnosis of AH
               increased risk.                                    ascites on ultrasonographic examination.
                                                                  based on results of clinical pathology or diagnostic
                                                                  imaging. Definitive diagnosis ultimately relies on histo-
               History and Clinical Signs                         logic examination of liver tissue. However, as animals
                                                                  with AH may be systemically unwell, liver biopsy is
               Clinical signs in dogs with AH are usually nonspecific and   often not performed in the acute setting, with patient
               similar to those described for CH. Interestingly, in one   treatment based on a tentative diagnosis. Fine needle
               study of dogs with AH, clinical signs had been present for   aspiration cytology is not reliable for the diagnosis of
               10.0 weeks (range, 0.5–52 weeks) before diagnosis. Again,   AH, and is not recommended.
               the clinician should pay particular attention to subtle wax-
               ing and waning GI signs, depression, lethargy, anorexia,
               weight loss, and polyuria and polydipsia. Clinical signs of   Therapy
               HE may also occur in the patient with AH. Physical exami-  Therapy for AH is aimed at the underlying cause, if
               nation findings are generally unremarkable, although the   known. However, as the etiology of most cases is cur-
               liver is occasionally palpably enlarged in the dog with AH.   rently not understood, treatment is generally sympto-
               Dogs with an infectious etiology may also be pyrexic and   matic and supportive. In one retrospective study, dogs
               show other signs of systemic disease.
                                                                  with AH were treated with antibiotics (5/16), hepatic
                                                                  support diet and ursodeoxycholic acid (7/16), and 5/16
                                                                  dogs were not treated. Due to the potential for an under-
               Diagnosis
                                                                  lying infectious cause, corticosteroids are usually avoided
               As discussed earlier, clinical pathology is usually the   in dogs with AH . The use of antiviral drugs in dogs with
               next step in the investigation of a dog with suspected   CAV‐1 infection has not been studied. Fluid therapy is
               AH. Clinical pathology findings include elevations of   required  if  the dog is  anorexic, and  short‐term nutri-
               liver enzymes, including ALT, AST, ALP, and GGT. In   tional support by methods of assisted enteral nutrition is
               one study, there was no significant difference in any rou-  sometimes also required.
               tine biochemical or hematologic variable between dogs
               with AH and CH. However, if liver function is assessed,   Prognosis
               it is more likely to be within the reference range in dogs
               with AH.                                           The prognosis for AH is variable, and likely dependent
                 Diagnostic imaging is often performed after clinical   on multiple factors, such as the etiology, severity of dis-
               pathology in the assessment of the dog with suspected   ease, and how early treatment is instigated. In a previous
               AH. Abdominal radiography can be used to assess liver   study, the median survival time of dogs with AH was 34.9
               size, although as detailed earlier, ultrasonography is   months. It is also possible that AH progresses to CH in
               the preferred imaging modality for the investigation of   some dogs. For instance, in a study of 12 dogs with AH
               liver disease. In one study of 21 dogs with a histologic   that had a repeat liver biopsy performed after approxi-
               diagnosis of AH, all apart from two had abnormalities   mately  six  weeks,  histopathology  revealed  complete
               detected on ultrasonographic examination of the liver.   remission of inflammatory and degenerative changes in
               Hepatic  size  was  assessed  as  normal  in  seven   six dogs, no changes in one dog, and progression from
               dogs,  enlarged in eight, and small in six. The  hepatic   AH to CH in five dogs.


                 Further Reading

               Bexfield N, Buxton R, Vicek T. Breed, age and gender   Poldervaart J, Favier R, Penning L, et al. Primary hepatitis
                 distribution of dogs with chronic hepatitis in the United   in dogs:a retrospective review (2001–2006). J Vet Intern
                 Kingdom. Vet J 2012; 193(1): 124–8.                Med 2009; 23(1): 72–80.
               Favier R. Poldevaart J, van den Ingh T, et al. A   Van den Ingh T, van Winkle T, Cullen J, et al. Morpho-
                 retrospective study of oral prednisolone treatment   logical classification of parenchymal disorders of the
                 in canine chronic hepatitis. Vet Quart 2013; 33(3):   canine and feline liver: hepatocellular death, hepatitis and
                 113–20.                                            cirrhosis. In: WSAVA Liver Standardization Group, eds.
   730   731   732   733   734   735   736   737   738   739   740